Neuroimaging in primary lateral sclerosis
Increased interest in the underlying pathogenesis of primary lateral sclerosis (PLS) and its
relationship to amyotrophic lateral sclerosis (ALS) has corresponded to a growing number of …
relationship to amyotrophic lateral sclerosis (ALS) has corresponded to a growing number of …
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas
R Laudicella, N Quartuccio, G Argiroffi, P Alongi… - European Journal of …, 2021 - Springer
Purpose The objective of this review was to explore the potential clinical application of
unconventional non-amino acid PET radiopharmaceuticals in patients with gliomas …
unconventional non-amino acid PET radiopharmaceuticals in patients with gliomas …
Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis
Purpose To investigate the whole-brain landscape of iron-related abnormalities in
amyotrophic lateral sclerosis (ALS) by using the in vivo MRI technique of quantitative …
amyotrophic lateral sclerosis (ALS) by using the in vivo MRI technique of quantitative …
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis
Objectives Positron emission tomography (PET) and volume of interest (VOI) analysis have
recently shown in amyotrophic lateral sclerosis (ALS) an accuracy of 93% in differentiating …
recently shown in amyotrophic lateral sclerosis (ALS) an accuracy of 93% in differentiating …
Prospective validation of 18F-FDG brain PET discriminant analysis methods in the diagnosis of amyotrophic lateral sclerosis
D Van Weehaeghe, J Ceccarini, A Delva… - Journal of Nuclear …, 2016 - Soc Nuclear Med
An objective biomarker for early identification and accurate differential diagnosis of
amyotrophic lateral sclerosis (ALS) is lacking. 18F-FDG PET brain imaging with advanced …
amyotrophic lateral sclerosis (ALS) is lacking. 18F-FDG PET brain imaging with advanced …
Therapeutic strategies under development targeting inflammatory mechanisms in amyotrophic lateral sclerosis
SG Crisafulli, S Brajkovic, MS Cipolat Mis… - Molecular …, 2018 - Springer
Amyotrophic lateral sclerosis (ALS) is a neurological disease characterized by the
progressive loss of cortical, bulbar, and spinal motor neurons (MNs). The cardinal …
progressive loss of cortical, bulbar, and spinal motor neurons (MNs). The cardinal …
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis …
L D'hulst, D Van Weehaeghe, A Chiò… - … Lateral Sclerosis and …, 2018 - Taylor & Francis
Abstract Objective: 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography
(PET) single-center studies using support vector machine (SVM) approach to differentiate …
(PET) single-center studies using support vector machine (SVM) approach to differentiate …
[HTML][HTML] Longitudinal 18F-FDG PET and MRI reveal evolving imaging pathology that corresponds to disease progression in a patient with ALS-FTD
V Rajagopalan, EP Pioro - Frontiers in neurology, 2019 - frontiersin.org
Single time point positron emission tomography (PET) studies of patients with amyotrophic
lateral sclerosis and frontotemporal dementia (ALS-FTD), have demonstrated …
lateral sclerosis and frontotemporal dementia (ALS-FTD), have demonstrated …
Brain positron emission tomography in idiopathic normal-pressure hydrocephalus: new 18F-fluorodeoxyglucose pattern in a long-known syndrome
Aim Patients with idiopathic normal-pressure hydrocephalus (iNPH) can show a global
reduction in cerebral glucose metabolism at [18 F] Fluorodeoxyglucose (FDG) PET. The …
reduction in cerebral glucose metabolism at [18 F] Fluorodeoxyglucose (FDG) PET. The …
18F-FDG PET/CT as a molecular biomarker in the diagnosis of amyotrophic lateral sclerosis associated with prostate cancer and progressive supranuclear palsy: A …
EA Cortés Mancera, FA Sinisterra Solis… - Frontiers in Nuclear …, 2023 - frontiersin.org
Introduction Amyotrophic lateral sclerosis (ALS) is a neurodegenerative, multisystem
disorder. Its clinical presentation typically consists of progressive focal muscle atrophy and …
disorder. Its clinical presentation typically consists of progressive focal muscle atrophy and …